Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTMT1 | Q9BV86 | 12/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.57 |
| ▸ | UGCG | Q16739 | 1/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31522582 | 0.92 | NTMT1 (0.61) | NTMT1CHRM2CHRM1CHRM3UGCG | |
| SCHEMBL31522593 | 0.91 | NTMT1 (0.57) | NTMT1UGCG | |
| SCHEMBL31522590 | 0.90 | NTMT1 (0.63) | NTMT1UGCG | |
| SCHEMBL31522586 | 0.88 | NTMT1 (0.54) | NTMT1UGCG | |
| SCHEMBL31522596 | 0.87 | NTMT1 (0.60) | NTMT1UGCG | |
| SCHEMBL16006996 | 0.86 | NTMT1 (0.66) | NTMT1CHRM2CHRM1CHRM3UGCG | |
| SCHEMBL16006997 | 0.86 | NTMT1 (0.66) | NTMT1CHRM2CHRM1CHRM3UGCG | |
| SCHEMBL19407264 | 0.85 | NTMT1 (0.62) | NTMT1CHRM2CHRM1CHRM3CHRNA7 | |
| SCHEMBL29415411 | 0.85 | NTMT1 (0.61) | NTMT1CHRM2CHRM1CHRM3UGCG | |
| SCHEMBL31522591 | 0.84 | NTMT1 (0.55) | NTMT1UGCGCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4559918-A2 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | Genzyme Corporation (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3673906-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORP (US) | 2025-05-14 | — | — | EP | disclosed |